Setting reasonable objectives for improving preemptive kidney transplantation rates in children.


Journal

Pediatric nephrology (Berlin, Germany)
ISSN: 1432-198X
Titre abrégé: Pediatr Nephrol
Pays: Germany
ID NLM: 8708728

Informations de publication

Date de publication:
12 2020
Historique:
received: 20 01 2020
accepted: 05 06 2020
revised: 07 05 2020
pubmed: 26 6 2020
medline: 3 9 2021
entrez: 26 6 2020
Statut: ppublish

Résumé

This study aims to develop a method to estimate the potential of preemptive kidney transplantation (PKT) by identifying patients who were transplanted after a dialysis period (non-preemptive kidney transplantation (NPKT)) despite being medically suitable for PKT. All children (< 18 years old) starting kidney replacement therapy (KRT) in France, between 2010 and 2016 and transplanted before December 31, 2017, were included. A propensity score (PS) of receiving PKT was estimated by multivariate logistic regression based on recipient medical characteristics. Healthcare use during the 24 months prior to KRT initiation was extracted from the French National Health Insurance database, and a pre-KRT follow-up of more than 18 months was considered sufficient to allow preemptive transplantation. Among 643 patients who started KRT, 149 (23.2%) were preemptively transplanted. Using PS stratification, among 391 NPKT patients, we identified 145 patients (37%) suitable for PKT, according to clinical characteristics. Mean age was 12.3 years, 67% were males, and 56% had urological abnormalities. Among those 145 patients, we identified 79 NPKT patients who started on dialysis despite early referral to a nephrologist (more than 18 months prior to KRT initiation). This method estimates a potential of 228 (149 + 79) PKT (35%) among pediatric patients in France. A similar method could be used in adults or in other countries. Estimation of the rate of patients with CKD stage 5 medically suitable for PKT will be of interest for health policy makers when setting up objectives for improvement in preemptive kidney transplant access.

Sections du résumé

BACKGROUND
This study aims to develop a method to estimate the potential of preemptive kidney transplantation (PKT) by identifying patients who were transplanted after a dialysis period (non-preemptive kidney transplantation (NPKT)) despite being medically suitable for PKT.
METHODS
All children (< 18 years old) starting kidney replacement therapy (KRT) in France, between 2010 and 2016 and transplanted before December 31, 2017, were included. A propensity score (PS) of receiving PKT was estimated by multivariate logistic regression based on recipient medical characteristics. Healthcare use during the 24 months prior to KRT initiation was extracted from the French National Health Insurance database, and a pre-KRT follow-up of more than 18 months was considered sufficient to allow preemptive transplantation.
RESULTS
Among 643 patients who started KRT, 149 (23.2%) were preemptively transplanted. Using PS stratification, among 391 NPKT patients, we identified 145 patients (37%) suitable for PKT, according to clinical characteristics. Mean age was 12.3 years, 67% were males, and 56% had urological abnormalities. Among those 145 patients, we identified 79 NPKT patients who started on dialysis despite early referral to a nephrologist (more than 18 months prior to KRT initiation).
CONCLUSIONS
This method estimates a potential of 228 (149 + 79) PKT (35%) among pediatric patients in France. A similar method could be used in adults or in other countries. Estimation of the rate of patients with CKD stage 5 medically suitable for PKT will be of interest for health policy makers when setting up objectives for improvement in preemptive kidney transplant access.

Identifiants

pubmed: 32583044
doi: 10.1007/s00467-020-04653-w
pii: 10.1007/s00467-020-04653-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2353-2360

Auteurs

Cyrielle Parmentier (C)

Pediatric Nephrology Unit, Armand Trousseau Hospital, APHP.6, 75012, Paris, France. cyrielle.parmentier@aphp.fr.
REIN Registry, Agence de la Biomedecine, La Plaine Saint-Denis, France. cyrielle.parmentier@aphp.fr.

Mathilde Lassalle (M)

REIN Registry, Agence de la Biomedecine, La Plaine Saint-Denis, France.

Etienne Berard (E)

Pediatric Nephrology Unit, CHU de Nice-Hôpital, Nice, France.

Justine Bacchetta (J)

Pediatric Nephrology Unit, Hôpital Femme Mère Enfant, Lyon, France.

Jean-Daniel Delbet (JD)

Pediatric Nephrology Unit, Armand Trousseau Hospital, APHP.6, 75012, Paris, France.

Jerome Harambat (J)

Pediatric Nephrology Unit, CHU de Bordeaux, Bordeaux, France.

Cécile Couchoud (C)

REIN Registry, Agence de la Biomedecine, La Plaine Saint-Denis, France.

Julien Hogan (J)

Pediatric Nephrology Unit, Robert-Debré Hospital, APHP, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH